Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$118.49

0.93 (0.79%)

, PFE

Pfizer

$32.50

-0.16 (-0.49%)

17:49
10/17/16
10/17
17:49
10/17/16
17:49

J&J trades lower after Pfizer announces availability of Remicade biosimilar

Shares of Johnson & Johnson (JNJ) are fractionally lower, down 0.41%, or 49c to $118 per share in after-hours trading after Pfizer (PFE) announced that the company will begin shipment of INFLECTRA for injection, a biosimilar of REMICADE to wholesalers in the United States in late November 2016.

JNJ

Johnson & Johnson

$118.49

0.93 (0.79%)

PFE

Pfizer

$32.50

-0.16 (-0.49%)

  • 18

    Oct

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

  • 06

    Nov

JNJ Johnson & Johnson
$118.49

0.93 (0.79%)

08/24/16
JEFF
08/24/16
NO CHANGE
Target $210
JEFF
Buy
Cooper Companies estimates raised at Jefferies after doctor survey
Jefferies analyst Anthony Petrone reports that the firm's survey of 52 new optometry practices suggest continued gains in dailies and stable share in monthlies for Cooper Companies (COO) and that Johnson & Johnson's (JNJ) Acuvue Vita is off to slow start. Based on the survey results, and a "significant" foreign exchange tailwind, Petrone raised his estimates for Cooper and increased his price target on the shares to $210 from $190. The firm has a Buy rating on Cooper shares.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
09/19/16
LEER
09/19/16
NO CHANGE
LEER
Abbott, Johnson & Johnson transaction positive for both companies, says Leerink
Leerink analyst Danielle Antalffy says the sale of Abbott's (ABT) Medical Optics ophthalmology business to Johnson & Johnson (JNJ) is positive for both companies. The deal strengthens Abbott's balance sheet and eliminates the need for a previously expected $3B capital raise, and adds a key component to Johnson & Johnson's already-strong vision care franchise, the analyst notes.
10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Johnson & Johnson weakness creates buying opportunity, says RBC Capital
RBC Capital analyst Glenn Novarro says that Johnson & Johnson underperformed the market in Q3 due to a number of factors including Remicade biosimilar risk and the pharma pricing debate. The analyst says that "these concerns are manageable/overblown," and he expects the company to report strong Q3 results, driven by a strong pharma performance. Novoroo expects the company's Q3 revenue to come in slightly above expectations, and he predicts that the company will narrow its 2016 EPS guidance to the high end of the previous range. The analyst recommends buying the stock. He keeps a $133 price target and Outperform rating on the shares.
PFE Pfizer
$32.50

-0.16 (-0.49%)

09/14/16
BMOC
09/14/16
NO CHANGE
BMOC
Pfizer should exceed fiscal 2016 guidance, says BMO Capital
BMO Capital analyst Alex Arfaei says that Pfizer should exceed its fiscal 2016 guidance. The analyst says that Medivation, which Pfizer agreed to acquire, gives Pfizer another growth driver. Additionally, Pfizer has a number of other "high margin specialty drugs," according to the analyst. He says that the stock's dividend yield is "attractive," and he keeps a $40 price target and Outperform rating on the shares.
10/07/16
ROTH
10/07/16
NO CHANGE
Target $160
ROTH
Buy
ICU Medical price target raised to $160 from $132 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for ICU Medical (ICUI) to $160 from $132 after the company announced an agreement to acquire Hospira Infusion Systems from Pfizer (PFE) for $1B. The analyst is overall positive on the deal as it removes the long-standing customer concentration overhang and grows ICU Medical into a legitimate pure-play infusion therapy company with a complete product portfolio. The company also preannounced Q3 preliminary results above expectations, he notes. Lewis reiterates a Buy rating on ICU Medical's shares.
10/13/16
JEFF
10/13/16
DOWNGRADE
Target $36
JEFF
Hold
Pfizer downgraded to Hold from Buy at Jefferies
Jefferies analyst Jeffrey Holford downgraded Pfizer (PFE) to Hold citing a lack of positive catalysts. The analyst says the drivers for his upgrade to Buy have either played out or have not materialized, namely an inversion or GEP unit separation. To reflect the infusion business disposal and weaker Ibrance trends, Holford cut his mid-term earnings estimates for Pfizer by up to 7% and cut his price target for the shares to $36 from $39. The stock closed yesterday down 6c to $33.07. The analyst also sees increased risk of a major acquisition occurring over the next 12 months. In the global pharma space, Holford lists AbbVie (ABBV), Eli Lilly (LLY), Novartis (NVS) and AstraZeneca (AZN) as his top picks.
10/13/16
10/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Bristol-Myers (BMY) downgraded to Buy from Conviction Buy at Goldman with analyst Jami Rubin saying disappointing CM-26 data adds a greater level of uncertainty to future trials. 2. Pfizer (PFE) downgraded to Hold from Buy at Jefferies with analyst Jeffrey Holford citing a lack of positive catalysts. 3. Coach (COH) downgraded to Mixed from Positive at OTR Global citing checks that indicate less competitive offerings, reduced promotions, and feedback of some share loss by store managers. 4. E-Trade (ETFC) downgraded to Neutral from Buy at BofA/Merrill. 5. Deckers Brands (DECK) downgraded to Negative from Neutral at Susquehanna with analyst Sam Poser saying he believes the health of the UGG brand is clearly at risk as the company has already started promotional activity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

16:47
06/27/17
06/27
16:47
06/27/17
16:47
Hot Stocks
Global Medical REIT provides update on acquisition of cardiac clinic in Lubbok »

Global Medical REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:46
06/27/17
06/27
16:46
06/27/17
16:46
Hot Stocks
Ryerson comments on Q2 market conditions, demand environment »

In a press release…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYI

Ryerson

$9.00

-0.1 (-1.10%)

16:43
06/27/17
06/27
16:43
06/27/17
16:43
Earnings
Ryerson sees Q2 net income $0M-$2M »

EPS consensus 35c. Says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
06/27/17
06/27
16:38
06/27/17
16:38
General news
API crude inventories for week of June 23 »

API reports that crude…

SSTK

Shutterstock

$43.81

-0.94 (-2.10%)

16:37
06/27/17
06/27
16:37
06/27/17
16:37
Hot Stocks
Shutterstock to acquire Flashstock for approximately $50M cash »

Shutterstock announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$77.77

0.26 (0.34%)

16:36
06/27/17
06/27
16:36
06/27/17
16:36
Hot Stocks
Aflac recommends shareholders to reject mini-tender offer by TRC Capital »

Aflac announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AL

Air Lease

$36.97

0.13 (0.35%)

, BA

Boeing

$198.89

-1.09 (-0.55%)

16:34
06/27/17
06/27
16:34
06/27/17
16:34
Hot Stocks
Air Lease delivers Boeing 737-800 to Travel Service »

Air Lease Corporation…

AL

Air Lease

$36.97

0.13 (0.35%)

BA

Boeing

$198.89

-1.09 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

CEMI

Chembio Diagnostics

16:33
06/27/17
06/27
16:33
06/27/17
16:33
Syndicate
Chembio establishes "at-the-market" program »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

OC

Owens Corning

$66.05

-0.65 (-0.97%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Owens Corning completes acquisition of Pittsburgh Corning for $560M »

Owens Corning announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLLS

Cellectis

$24.34

-0.69 (-2.76%)

16:32
06/27/17
06/27
16:32
06/27/17
16:32
Hot Stocks
Cellectis announces first in human administration in AML study »

Cellectis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

NSAT

Norsat

$11.50

0.1 (0.88%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Norsat receives court approval for arrangement with Hytera Communications »

Norsat International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEET

Meet Group

$4.85

0.01 (0.21%)

16:31
06/27/17
06/27
16:31
06/27/17
16:31
Hot Stocks
Meet Group reaches agreement with Harvest Capital »

The Meet Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/27/17
06/27
16:30
06/27/17
16:30
Options
Preliminary option volume of 15.8M today »

Preliminary option volume…

16:25
06/27/17
06/27
16:25
06/27/17
16:25
Conference/Events
CFA Society of North Carolina to hold a panel discussion »

The CFA Society of North…

CVS

CVS Health

$80.49

0.37 (0.46%)

16:20
06/27/17
06/27
16:20
06/27/17
16:20
Initiation
CVS Health initiated  »

CVS Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$77.26

-0.27 (-0.35%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
Initiation
Walgreens Boots Alliance initiated  »

Walgreens Boots Alliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

S

Sprint

$8.18

0.17 (2.12%)

, TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

16:19
06/27/17
06/27
16:19
06/27/17
16:19
General news
On The Fly: Top stock stories for Tuesday »

Stocks moved in a very…

S

Sprint

$8.18

0.17 (2.12%)

TMUS

T-Mobile

$61.01

-2.14 (-3.39%)

CMCSA

Comcast

$39.25

-0.34 (-0.86%)

CHTR

Charter

$329.87

-2.78 (-0.84%)

VZ

Verizon

$44.84

-0.91 (-1.99%)

T

AT&T

$37.70

-0.45 (-1.18%)

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

MRK

Merck

$65.54

-0.38 (-0.58%)

MDLZ

Mondelez

$43.97

-0.93 (-2.07%)

WPPGY

WPP PLC

$104.96

-0.97 (-0.92%)

FDX

FedEx

$214.39

-0.97 (-0.45%)

CBI

CB&I

$20.02

5.62 (39.03%)

DRI

Darden

$92.69

2.61 (2.90%)

WDC

Western Digital

$91.85

-0.81 (-0.87%)

STX

Seagate

$39.51

-2.88 (-6.79%)

RARX

RA Pharmaceuticals

$17.69

-4.49 (-20.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 28

    Jun

  • 07

    Jul

  • 18

    Jul

  • 19

    Jul

  • 19

    Jul

  • 27

    Jul

  • 27

    Jul

  • 03

    Aug

  • 21

    Sep

  • 22

    Sep

CEMI

Chembio Diagnostics

16:18
06/27/17
06/27
16:18
06/27/17
16:18
Syndicate
Breaking Syndicate news story on Chembio Diagnostics »

Chembio Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

$NSD

NASDAQ Market Internals

16:17
06/27/17
06/27
16:17
06/27/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$23.32

-0.61 (-2.55%)

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Initiation
Square initiated  »

Square assumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

$NYE

NYSE Market Internals

16:16
06/27/17
06/27
16:16
06/27/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$52.73

-1.01 (-1.88%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
PayPal initiated  »

PayPal assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

CFI

Culp

$32.25

-0.25 (-0.77%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Hot Stocks
Culp changes NYSE ticker symbol to 'CULP' »

Culp, Inc. announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAWK

Blackhawk

$41.90

-1.1 (-2.56%)

16:15
06/27/17
06/27
16:15
06/27/17
16:15
Initiation
Blackhawk initiated  »

Blackhawk initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$109.76

-1.25 (-1.13%)

16:14
06/27/17
06/27
16:14
06/27/17
16:14
Hot Stocks
UPS to freeze retirement plan benefits for non-union employees »

United Parcel Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.